Search the Newsreel

Kaltura Inc (KLTR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Kaltura Inc (KLTR), detailing its current price momentum score of 4.24 and identifying support and resistance levels. It outlines various technical indicators like MACD, RSI, and moving averages, offering buy, sell, or neutral signals. The analysis suggests …

Chemfab Alkalis Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Alkali Metals records ₹930 crore revenue, turns profitable in FY26

Kaltura (KLTR) to Post Earnings on Wednesday

Kalaris Therapeutics Inc (KLRS) Financial Health: Profitability & Balance Sheet Analysis

Kalaris Therapeutics Inc (KLRS) has a financial score of 5.56, placing it 341 out of 385 in the Biotechnology & Medical Research industry, indicating robust financial status but low operating efficiency. The article notes that relevant financial data for key metrics such as total …

Kaltura Inc (KLTR) Valuation: PE, PB & Fair Value Analysis

Kaltura Inc (KLTR) has a current valuation score of 8.37, placing it 223rd out of 486 companies in the Software & IT Services industry. The company's P/E ratio is -14.77, which is a significant decline from its recent high. Other key valuation metrics like …

Lords Chloro Alkali posts record Q1FY27 PAT of ₹14.96 crore

LORDSCHLO: Strong Q1 FY27 profit growth, new ESOP scheme, and higher borrowing limits approved

Lords Chloro Alkali Share Price: Q1 FY26માં કંપનીનો નફો 43% વધી ₹14.95 કરોડ થયો, શેરધારકોની મંજૂરી જરૂરી

Lords Chloro Alkali: లాభాల్లో దూసుకుపోయిన కంపెనీ.. Q1 FY26లో **43%** జంప్!

Lords Chloro Alkali: லாபம் **43%** உயர்வு! முதலீட்டாளர்களுக்கு குட் நியூஸ்

Lords Chloro Alkali Q1 FY26 Profit Jumps 43% to ₹14.95 Crore

Kaltura Inc (KLTR) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Kaltura Inc (KLTR) stock's dividend and stock split history. It indicates that Kaltura Inc has not distributed any dividends over the past five years. The page displays current stock metrics such as market cap and price, but shows …

Kaltura Delivers Record-Scale Live Streaming for the 2026 FIFA World Cup, Previews Agentic Avatar Experiences for Live Sports

Kaltura successfully delivered record-scale live streaming for the 2026 FIFA World Cup, handling over 1.3 billion playback sessions and peaking at 7 million concurrent sessions across multiple regions. The company re-architected its platform to microservices and deployed AI agents to manage operations, significantly enhancing …

Kaltura Inc (KLTR) Financial Health: Profitability & Balance Sheet Analysis

Kaltura Inc (KLTR) has a current financial score of 6.56, placing it 335th out of 486 in the Software & IT Services industry, indicating stable financial status but average operating efficiency. The company's latest quarterly revenue decreased by 5.02% year-over-year to $44.63M, and its …

Kalaris Therapeutics Inc (KLRS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Kalaris Therapeutics Inc (KLRS) focusing on its dividend history and stock split events. It states that the company has not distributed any dividends over the past five years but lists a significant merger-related stock split scheduled for January …

Lords Chloro Alkali के निवेशकों की बल्ले-बल्ले! Q1 में मुनाफा **240%** उछला, ₹500 Cr उधार लेने की मंजूरी

LORDSCHLO: Record quarterly profit and income, with renewables driving cost and margin improvements

Interested In Kalyani Steels' (NSE:KSL) Upcoming ₹10.00 Dividend? You Have Three Days Left

Kalaris Therapeutics Inc (KLRS) Cash Flow Statement

This article provides the cash flow statement for Kalaris Therapeutics Inc (KLRS), detailing its operating, investing, and financing cash flows on both quarterly and annual bases up to FY2026Q1. It includes financial figures and year-over-year percentage changes for various cash flow components. The article …

KLRS|Kalaris Therapeutics Inc|Price:3.730|Chg%:-0.190

Kalaris Therapeutics Inc (KLRS) is a clinical-stage biopharmaceutical company focusing on treatments for retinal diseases, with its stock currently priced at $3.73. The company is developing TH103, an anti-VEGF investigational therapy, which is in a Phase I clinical trial for neovascular age-related macular degeneration. …

Kaltura CFO Azaria Eynav sells 6,301 shares for $8,970

Kaltura CFO Azaria Eynav sold 6,301 common shares on July 22, 2026, at a weighted average price of $1.42, totaling $8,970. Following this transaction, Eynav's beneficial ownership in Kaltura fell to 2.16 million shares. This news brief was generated by Public Technologies (PUBT) using …

KLTR|Kaltura Inc|Price:1.649|Chg%:-0.101

PT Pelayaran Nasional Ekalya Purnamasari Tbk Revenue Breakdown – IDX:ELPI

KAL Group Limited Revenue Breakdown – JSE:KAL

KLTR|Kaltura Inc|Price:1.400|Chg%:+0.030

Kaltura Inc. (KLTR) is currently trading at $1.40 with a 2.19% increase. TradingKey's analysis indicates good fundamental health and high growth potential for the company, though its valuation is considered fair within the Software & IT Services industry. Institutional ownership is high, and analysts …

Kaltura (KLTR) officer sells 6,301 shares under Rule 10b5-1 plan

Kaltura Inc. officer Azaria Eynav sold 6,301 shares of common stock on July 22, 2026, at a weighted average price of $1.4239 per share, totaling approximately $9,000. This transaction was executed under a pre-established Rule 10b5-1 trading plan adopted on December 15, 2025. Following …

PT Kalbe Farma Tbk Revenue Breakdown – IDX:KLBF

Kalamazoo Resources Completes Placement of 65.6 Million Shares Under Corporations Act Relief

Gujarat Alkalies & Chemicals profit surges 5.8x in Q1FY26, approves ₹55 Cr unit

Kalyani Steels sets July 31 deadline for TDS compliance on dividend

Gujarat Alkalies & Chemicals Posts Record Q1FY27 Revenue, PBT Surges 1,000%

Kalaris Therapeutics (KLRS) awards 220,000 stock options to its CFO

Kalaris Therapeutics (KLRS) has granted its Chief Financial Officer, Liisa Ann Bayko, 220,000 stock options. These options, with an exercise price of $4.00 per share and an expiration date of July 19, 2036, will vest over four years. The first 25% vests on July …

Eynav Azaria Sells 6,257 Shares of Kaltura Inc (KLTR)

Eynav Azaria, an insider at Kaltura Inc (KLTR), sold 6,257 shares on July 21, 2026, reducing their holdings to 2,162,823 shares. This transaction is part of a pattern where insiders have sold significantly more shares than they have bought over the past year. Kaltura …

Form 4 Kaltura Inc For: 22 July By Investing.com

This article reports on a Form 4 filing for Kaltura Inc. on July 22, 2026. The piece is brief, providing only the title and the company name with its stock symbol and a small gain. Most of the content consists of market data and …

Kaltura Inc (KLTR) insider sells 6,257 shares under 10b5-1 plan

Kaltura Inc officer Azaria Eynav sold a total of 6,257 shares of common stock in two transactions on July 20 and July 21, 2026. These sales were executed under a Rule 10b5-1 trading plan adopted on December 15, 2025. The shares were sold at …